Simone de Araújo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Simone de Araújo has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Erick Bryan de Sousa Lima
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
2 shared publications - Jand Venes Rolim Medeiros
Universidade Federal do Delta do Parnaíba
2 shared publications - Ana Carolina Machado Leódido
Universidade Federal do Delta do Parnaíba; Secretaria Estadual de Saúde
1 shared publication - Ana Caroline Ventris de Godoy
INCT-Nanobiofar, Department of Physiology and Biophysics (R.A.S.S., A.S.M.B., C.F.B., M.F.I., F.A.S., S.C.A.G., L.R.-R., K.S.F., S.S., I.Z.L.F.F., U.F.V.-M., A.C.V.G., A.H.A.M., M.E., B.S., A.M., G.M., N.P.S., D.A.A.P., J.R.R., M.L.D.-P., D.M.-S., M.A.P.F., A.S.H., T.V.-B., S.G., M.F.L., M.J.C.-S.), Federal University of Minas Gerais (UFMG), Brazil
1 shared publication - Ana Clara Silva Sales
Universidade Federal do Delta do Parnaíba
1 shared publication Ana Lúcia P. Freitas
Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Ceará, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 98 (1) , e20240815
Protective effect of latex proteins from Plumeria pudica against acetaminophen-induced acute liver injury
The protein fraction from Plumeria pudica latex (LPPp) was evaluated against APAP-induced liver injury in mice. Key measurements included total leukocyte count, liver weight, AST, ALT, liver levels of MDA, GSH, SOD, MPO, NO3/NO2 concentration, cytokines TNF-α, IL-β, IL-6, IL-10, IFN- γ, and CXCL1. Histopathological and immunohistochemical analysis were conducted, and proteins in LPPp were identified by mass spectrometry. Molecular docking analyses were performed with LPPp proteins and APAP, NAPQI, TNF-α, and IFN-α. LPPp reduced liver weight, ALT, and AST levels, and prevented the decrease in total leukocyte count, indicating protection against liver injury. It also reduced MDA levels and preserved GSH and SOD levels, showing its antioxidant properties. LPPp significantly inhibited MPO and NO3/NO2 levels, reducing inflammation. LPPp decreased levels of TNF-α, IL-β, IL-6, IFN-γ, and CXCL1, while IL-10 levels remained elevated, suggesting an anti-inflammatory response. Histological analysis showed preserved liver tissue, and anti-Ly6C immunostaining indicated reduced neutrophil accumulation. Molecular docking revealed that latex cysteine proteases had a higher affinity for APAP and NAPQI, while a proteinase inhibitor showed affinity for CYP2EI, TNF-α, and IFN-α. These findings suggest that LPPp protects against APAP hepatotoxicity by interfering with APAP and NAPQI metabolism, reducing oxidative stress and inflammation, thus preventing hepatocyte damage.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 98 (1) , e20240815
Open AccessProtective effect of latex proteins from Plumeria pudica against acetaminophen-induced acute liver injury
The protein fraction from Plumeria pudica latex (LPPp) was evaluated against APAP-induced liver injury in mice. Key measurements included total leukocyte count, liver weight, AST, ALT, liver levels of MDA, GSH, SOD, MPO, NO3/NO2 concentration, cytokines TNF-α, IL-β, IL-6, IL-10, IFN- γ, and CXCL1. Histopathological and immunohistochemical analysis were conducted, and proteins in LPPp were identified by mass spectrometry. Molecular docking analyses were performed with LPPp proteins and APAP, NAPQI, TNF-α, and IFN-α. LPPp reduced liver weight, ALT, and AST levels, and prevented the decrease in total leukocyte count, indicating protection against liver injury. It also reduced MDA levels and preserved GSH and SOD levels, showing its antioxidant properties. LPPp significantly inhibited MPO and NO3/NO2 levels, reducing inflammation. LPPp decreased levels of TNF-α, IL-β, IL-6, IFN-γ, and CXCL1, while IL-10 levels remained elevated, suggesting an anti-inflammatory response. Histological analysis showed preserved liver tissue, and anti-Ly6C immunostaining indicated reduced neutrophil accumulation. Molecular docking revealed that latex cysteine proteases had a higher affinity for APAP and NAPQI, while a proteinase inhibitor showed affinity for CYP2EI, TNF-α, and IFN-α. These findings suggest that LPPp protects against APAP hepatotoxicity by interfering with APAP and NAPQI metabolism, reducing oxidative stress and inflammation, thus preventing hepatocyte damage.
- Open Access
- 5 September 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (12)
A minireview of pharmacotherapy of type 2 diabetes – drugs and mechanisms
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that originates from numerous pathogenic mechanisms, all of which result in hyperglycemia. This disease is a major cause of morbidity and mortality worldwide. Effective prevention and treatment strategies for T2DM are therefore necessary. The purpose of this review was to summarize the pharmacotherapy for patients with T2DM by discussing its pathophysiology, the therapeutic classes used in treatment strategies, as well as the mechanisms of action for each one. A literature review was conducted by searching Google Scholar, PubMed, and Science Direct databases using the search terms: type 2 diabetes mellitus, insulin, AMPK, antidiabetic drugs, incretin, SGLT2, and biguanides covering studies up to 2022. The review identified and included studies including qualitative, original research articles, and randomized controlled trial designs. The results of this study are divided into drugs that increase insulin sensitivity (e.g., biguanides, and thiazolidinediones), secretagogues (e.g., sulfonylureas, and meglitinides or glinides), incretin mimetics drugs (e.g., GLP-1 receptor agonists, and DPP-4 inhibitors), drugs that cause glycosuria (e.g., SGLT2 inhibitors), drugs that prevent glucose absorption (e.g., α-glucosidase inhibitor), and insulin. This allows the readers to understand each process while keeping the paper concise.
- 5 September 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (12)
Open AccessA minireview of pharmacotherapy of type 2 diabetes – drugs and mechanisms
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that originates from numerous pathogenic mechanisms, all of which result in hyperglycemia. This disease is a major cause of morbidity and mortality worldwide. Effective prevention and treatment strategies for T2DM are therefore necessary. The purpose of this review was to summarize the pharmacotherapy for patients with T2DM by discussing its pathophysiology, the therapeutic classes used in treatment strategies, as well as the mechanisms of action for each one. A literature review was conducted by searching Google Scholar, PubMed, and Science Direct databases using the search terms: type 2 diabetes mellitus, insulin, AMPK, antidiabetic drugs, incretin, SGLT2, and biguanides covering studies up to 2022. The review identified and included studies including qualitative, original research articles, and randomized controlled trial designs. The results of this study are divided into drugs that increase insulin sensitivity (e.g., biguanides, and thiazolidinediones), secretagogues (e.g., sulfonylureas, and meglitinides or glinides), incretin mimetics drugs (e.g., GLP-1 receptor agonists, and DPP-4 inhibitors), drugs that cause glycosuria (e.g., SGLT2 inhibitors), drugs that prevent glucose absorption (e.g., α-glucosidase inhibitor), and insulin. This allows the readers to understand each process while keeping the paper concise.
- 1 May 2016
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 86, 865-875
The efficacy of a sulphated polysaccharide fraction from Hypnea musciformis against diarrhea in rodents
- 1 May 2016
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 86, 865-875
The efficacy of a sulphated polysaccharide fraction from Hypnea musciformis against diarrhea in rodents